Grupo Procaps
Grupo Procaps (Procaps, S.A.) is a Colombia-based pharmaceutical group that develops, manufactures, and markets prescription, hospital, OTC, and diabetes-care medicines across 11 Latin American countries through four therapeutic lines.
- Company typePrivate
- Founded-
- HeadquartersRegional Presence
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Grupo Procaps does
Grupo Procaps (legal entity Procaps, S.A.) is a Colombia-based pharmaceutical group operating across 11 Latin American countries. The company develops, manufactures, and markets pharmaceutical products through four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (highly complex hospital medicines for critical processing), Vital Care (over-the-counter and generic health products for family wellness), and Diabetrics (well-being and chronic-condition management solutions for people with diabetes and their caregivers). The portfolio is extended to consumers through branded portals such as Diabetrics.com, gumivit.com.co, and dolofen.com.co.
The company runs a multi-channel go-to-market model combining direct sales to hospitals and healthcare providers for Clinical Specialities products, retail and pharmacy distribution for OTC and generic products across 11 Latin American countries, and direct-to-consumer e-commerce through its brand portals. Brand engagement is supported by an active presence on Twitter/X (@GrupoProcaps), LinkedIn, Instagram (@procapslatam), and YouTube (@ProcapsLatam). The company operates as a private entity (no public ticker, exchange listing, or disclosed parent), and explicitly disclaims any U.S. operations or affiliation with the U.S.-based ProCaps Laboratories.
Key data gaps relevant to investment analysis: no revenue or financial figures are disclosed; the listed headcount of 25 in the firmographics header is inconsistent with the breadth of operations and the headcount array is empty; no management team, ownership structure, funding history, M&A activity, patents, trademarks, or certifications are disclosed in the available data, despite the website referencing a certifications page; and no AI/ML capabilities or API/SDK offerings are documented. These gaps materially limit confidence in any quantitative assessment.
Grupo Procaps firmographics
Firmographics- Name
- Grupo Procaps
- Legal name
- Procaps, S.A.
- Website
- https://grupoprocaps.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Grupo Procaps (Procaps, S.A.) is a Colombia-based pharmaceutical group that develops, manufactures, and markets prescription, hospital, OTC, and diabetes-care medicines across 11 Latin American countries through four therapeutic lines.
- Ownership category
- akta.pro rank
Grupo Procaps industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Grupo Procaps is headquartered
LocationHeadquarters
- HQ city
- Regional Presence
Offices1 record
Markets served
Grupo Procaps business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Product Sales: Procaps generates revenue through the development, manufacture, and marketing of pharmaceutical products across four therapeutic lines: Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes wellness products).
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Grupo Procaps product offering
Product offeringCore offering
Grupo Procaps develops, manufactures, and markets pharmaceutical products across Latin America, operating four therapeutic lines: prescription brand medicines (Farma), complex hospital medicines (Clinical Specialities), OTC and generic health products (Vital Care), and diabetes management solutions (Diabetrics). The company operates in 11 Latin American countries and distributes through retail pharmacies, direct hospital sales, and brand e-commerce portals such as Gumivit and Dolofen.
Product overview
Grupo Procaps is a pharmaceutical company organized around four core therapeutic lines—Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions)—which together form a unified portfolio addressing both prescription and consumer health needs. The company also maintains branded product portals including Gumivit (gum and vitamin products) and Dolofen (pain relief), extending its consumer reach through dedicated digital channels.
Differentiator
Problem solved
Functional benefit
Brands
- Diabetrics: Well-being and quality of life services for people with diabetes (PWD), providing chronic condition management support.
- Farma
- Clinical Specialities
- Vital Care
- Gumivit
- Dolofen
Products and services
- Farma
Companies that use Grupo Procaps
Customer profileSegments4 records
Ideal customer profiles3 records
Grupo Procaps technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Grupo Procaps partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Grupo Procaps competitors and assessment
Company assessmentBroad incumbents
- Sanofi: Global pharmaceutical major with established diabetes (Lantus, Toujeo) and consumer health franchises across Latin America. Comparable to Procaps in primary care prescription and diabetes therapeutic areas, and a key competitor in Diabetrics.
Regional players
- Laboratorios Tecnoquímicas: Colombian pharmaceutical manufacturer of OTC and personal care products primarily serving Colombia and select Andean markets. Comparable in geographic anchor (Colombia) and consumer health (OTC/generic) therapeutic mix.
Direct peers
- Laboratorios Pisa: Mexican pharmaceutical manufacturer with focus on generic, branded generic, and hospital products distributed across Latin America. Comparable to Procaps' generics, hospital specialty, and multi-country LatAm operations.
- Genomma Lab Internacional: Mexican pharmaceutical company focused on OTC and personal care products marketed across Latin America. Comparable to Procaps' Vital Care (OTC) and Diabetrics (consumer chronic care) consumer health lines and shared multi-country LatAm distribution model.
- Grupo EMS: Largest pharmaceutical company in Brazil, manufacturing branded prescription, generic, OTC, and hospital products across Latin America. Directly comparable to Grupo Procaps in therapeutic line breadth, manufacturing footprint, and mass-market regional reach.
- Laboratorios Bagó: Argentine pharmaceutical group with presence across Latin America manufacturing prescription, hospital, and OTC products. Comparable to Procaps in multi-country LatAm manufacturing, therapeutic line structure, and emphasis on branded prescription medicines.
- Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with operations across Latin America producing branded generics, prescription medicines, OTC, and hospital products. Closely comparable to Procaps in product mix (Rx, OTC, hospital) and multi-country LatAm presence.
- Aché Laboratórios Farmacêuticos: Brazilian pharmaceutical company with branded generics, prescription, and OTC product portfolio sold across Latin America. Comparable to Procaps in prescription and OTC therapeutic mix plus regional LatAm footprint.
- Laboratorios Richmond: Argentine pharmaceutical laboratory manufacturing branded and generic products across multiple therapeutic areas with Latin American distribution. Comparable to Procaps in branded prescription medicines and multi-country LatAm reach.
Others
- Laboratorios Siegfried: Switzerland-based pharmaceutical manufacturer with strong presence in Latin America producing branded prescription medicines and generics. Comparable to Procaps as a manufacturer of branded prescription pharmaceuticals with multi-country LatAm distribution.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Grupo Procaps social profiles
Digital presenceGrupo Procaps financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grupo Procaps leadership team
Management profileNumber of profiles
Grupo Procaps funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grupo Procaps M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grupo Procaps
What does Grupo Procaps do?
Grupo Procaps develops, manufactures, and markets pharmaceutical products across Latin America, operating four therapeutic lines: prescription brand medicines (Farma), complex hospital medicines (Clinical Specialities), OTC and generic health products (Vital Care), and diabetes management solutions (Diabetrics). The company operates in 11 Latin American countries and distributes through retail pharmacies, direct hospital sales, and brand e-commerce portals such as Gumivit and Dolofen.
Is Grupo Procaps a public or private company?
Grupo Procaps is a private company. It is classified as unknown and is currently operating.
When was Grupo Procaps founded?
Grupo Procaps was founded in -1. It employs 11 to 50 people.
Where is Grupo Procaps based?
Grupo Procaps is headquartered in Regional Presence.
How does Grupo Procaps make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Grupo Procaps's main competitors?
Sanofi is listed as a broad incumbent. Laboratorios Tecnoquímicas is listed as a regional player. Direct peers are Laboratorios Pisa, Genomma Lab Internacional, Grupo EMS, Laboratorios Bagó, Eurofarma Laboratórios, Aché Laboratórios Farmacêuticos and Laboratorios Richmond. Laboratorios Siegfried is listed as an others.
Does Grupo Procaps have an API?
No public API is recorded for Grupo Procaps.
What industry is Grupo Procaps in?
Grupo Procaps's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 3254 and its SIC code is 2834.